Table 1

Cohort characteristics

 HCM (n = 30)Athletes (n = 60)
Age, years43.6 ± 14.243.8 ± 14.9
Sex, male24 (80%)48 (80%)
Race, White30 (100%)60 (100%)
Weight, kg80.6 ± 14.979.7 ± 11.5
Height, cm175.0 ± 7.1177.8 ± 8.9
ppV˙O2, %125 ± 27124 ± 25
Current physical activity levela
Competitive athlete9 (30.0%)28 (46.7%)
 Competitive endurance athlete7 (23.3%)18 (30.0%)
 Competitive Team athlete2 (6.7%)10 (16.7%)
Recreational athlete10 (33.3%)32 (53.3%)
 Recreational endurance athlete5 (16.7%)14 (23.3%)
 Recreational mixed sport athlete5 (16.7%)18 (30.0%)
Physically active11 (36.7%)0 (0%)
HCM morphology
Apical predominant17 (56.7)
Asymmetric septal11 (36.7)
Symmetric2 (6.7)
HCM characteristics
Maximal wall thickness, mmb16 [2]
ICD present at time of testing1 (3.3%)
 HCM (n = 30)Athletes (n = 60)
Age, years43.6 ± 14.243.8 ± 14.9
Sex, male24 (80%)48 (80%)
Race, White30 (100%)60 (100%)
Weight, kg80.6 ± 14.979.7 ± 11.5
Height, cm175.0 ± 7.1177.8 ± 8.9
ppV˙O2, %125 ± 27124 ± 25
Current physical activity levela
Competitive athlete9 (30.0%)28 (46.7%)
 Competitive endurance athlete7 (23.3%)18 (30.0%)
 Competitive Team athlete2 (6.7%)10 (16.7%)
Recreational athlete10 (33.3%)32 (53.3%)
 Recreational endurance athlete5 (16.7%)14 (23.3%)
 Recreational mixed sport athlete5 (16.7%)18 (30.0%)
Physically active11 (36.7%)0 (0%)
HCM morphology
Apical predominant17 (56.7)
Asymmetric septal11 (36.7)
Symmetric2 (6.7)
HCM characteristics
Maximal wall thickness, mmb16 [2]
ICD present at time of testing1 (3.3%)

Continuous variables are presented as mean ± SD or median [IQR]. Categorical variables are presented as n (%).

HCM, hypertrophic cardiomyopathy; ppV˙O2, per cent predicted peak oxygen consumption; CD, implantable cardioverter-defibrillator.

aCompetitive athlete defined as one that regularly participates in organized competitions. Team athlete defined as one that competes as part of an organized team. Recreational athlete defined as one that regularly trains intensely with personal goals but does not compete against others. Endurance athlete defined as one that predominantly participates in endurance sports (i.e. running, cycling, rowing, swimming, and triathlon). Mixed sport athlete defined as one that participates in a mixture of sports, including endurance, team, lifting, and/or is regularly and intensely active as part of occupation (i.e. armed services or personal trainer). Physically active individuals defined as meeting at least guideline-recommended minimum recommended ‘aerobic’ activity levels (>150 min/week of moderate and/or >75 min/week of intense ‘aerobic’ physical activity).

bHCM participants had maximal WT of ≥15 mm with the exception of n = 2 individuals with 13–14 mm maximal WT in the setting of a documented family history of HCM. Maximal WT was derived from cardiac magnetic resonance imaging (CMR) in 25 participants and transthoracic echocardiography in 5 participants who did not have CMR data available (e.g. severe claustrophobia, low quality CMR, no recent CMR since ICD placement and outside CMR without available images).

Table 1

Cohort characteristics

 HCM (n = 30)Athletes (n = 60)
Age, years43.6 ± 14.243.8 ± 14.9
Sex, male24 (80%)48 (80%)
Race, White30 (100%)60 (100%)
Weight, kg80.6 ± 14.979.7 ± 11.5
Height, cm175.0 ± 7.1177.8 ± 8.9
ppV˙O2, %125 ± 27124 ± 25
Current physical activity levela
Competitive athlete9 (30.0%)28 (46.7%)
 Competitive endurance athlete7 (23.3%)18 (30.0%)
 Competitive Team athlete2 (6.7%)10 (16.7%)
Recreational athlete10 (33.3%)32 (53.3%)
 Recreational endurance athlete5 (16.7%)14 (23.3%)
 Recreational mixed sport athlete5 (16.7%)18 (30.0%)
Physically active11 (36.7%)0 (0%)
HCM morphology
Apical predominant17 (56.7)
Asymmetric septal11 (36.7)
Symmetric2 (6.7)
HCM characteristics
Maximal wall thickness, mmb16 [2]
ICD present at time of testing1 (3.3%)
 HCM (n = 30)Athletes (n = 60)
Age, years43.6 ± 14.243.8 ± 14.9
Sex, male24 (80%)48 (80%)
Race, White30 (100%)60 (100%)
Weight, kg80.6 ± 14.979.7 ± 11.5
Height, cm175.0 ± 7.1177.8 ± 8.9
ppV˙O2, %125 ± 27124 ± 25
Current physical activity levela
Competitive athlete9 (30.0%)28 (46.7%)
 Competitive endurance athlete7 (23.3%)18 (30.0%)
 Competitive Team athlete2 (6.7%)10 (16.7%)
Recreational athlete10 (33.3%)32 (53.3%)
 Recreational endurance athlete5 (16.7%)14 (23.3%)
 Recreational mixed sport athlete5 (16.7%)18 (30.0%)
Physically active11 (36.7%)0 (0%)
HCM morphology
Apical predominant17 (56.7)
Asymmetric septal11 (36.7)
Symmetric2 (6.7)
HCM characteristics
Maximal wall thickness, mmb16 [2]
ICD present at time of testing1 (3.3%)

Continuous variables are presented as mean ± SD or median [IQR]. Categorical variables are presented as n (%).

HCM, hypertrophic cardiomyopathy; ppV˙O2, per cent predicted peak oxygen consumption; CD, implantable cardioverter-defibrillator.

aCompetitive athlete defined as one that regularly participates in organized competitions. Team athlete defined as one that competes as part of an organized team. Recreational athlete defined as one that regularly trains intensely with personal goals but does not compete against others. Endurance athlete defined as one that predominantly participates in endurance sports (i.e. running, cycling, rowing, swimming, and triathlon). Mixed sport athlete defined as one that participates in a mixture of sports, including endurance, team, lifting, and/or is regularly and intensely active as part of occupation (i.e. armed services or personal trainer). Physically active individuals defined as meeting at least guideline-recommended minimum recommended ‘aerobic’ activity levels (>150 min/week of moderate and/or >75 min/week of intense ‘aerobic’ physical activity).

bHCM participants had maximal WT of ≥15 mm with the exception of n = 2 individuals with 13–14 mm maximal WT in the setting of a documented family history of HCM. Maximal WT was derived from cardiac magnetic resonance imaging (CMR) in 25 participants and transthoracic echocardiography in 5 participants who did not have CMR data available (e.g. severe claustrophobia, low quality CMR, no recent CMR since ICD placement and outside CMR without available images).

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close